Chang-En Yu

9.0k total citations · 2 hit papers
34 papers, 4.7k citations indexed

About

Chang-En Yu is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Chang-En Yu has authored 34 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Physiology and 8 papers in Genetics. Recurrent topics in Chang-En Yu's work include Alzheimer's disease research and treatments (15 papers), DNA Repair Mechanisms (7 papers) and Bioinformatics and Genomic Networks (6 papers). Chang-En Yu is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), DNA Repair Mechanisms (7 papers) and Bioinformatics and Genomic Networks (6 papers). Chang-En Yu collaborates with scholars based in United States, Japan and Germany. Chang-En Yu's co-authors include Gerard D. Schellenberg, Ellen M. Wijsman, Junko Oshima, Ying‐Hui Fu, Thomas D. Bird, Fuki M. Hisama, George M. Martin, Jun Nakura, John Mulligan and Reid S. Alisch and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Chang-En Yu

34 papers receiving 4.6k citations

Hit Papers

Candidate Gene for the Ch... 1995 2026 2005 2015 1995 1996 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chang-En Yu 2.9k 2.3k 752 580 479 34 4.7k
Richard Killick 2.1k 0.7× 1.6k 0.7× 486 0.6× 887 1.5× 453 0.9× 84 4.0k
Ryozo Kuwano 2.7k 0.9× 1.2k 0.5× 783 1.0× 640 1.1× 324 0.7× 153 4.6k
Fang Cai 1.8k 0.6× 1.7k 0.7× 415 0.6× 905 1.6× 427 0.9× 91 4.2k
Junko Oshima 6.7k 2.3× 3.0k 1.3× 940 1.3× 549 0.9× 466 1.0× 125 8.7k
Eric B. Dammer 3.6k 1.3× 2.2k 1.0× 525 0.7× 626 1.1× 248 0.5× 138 6.5k
Suzanne Y. Guénette 2.2k 0.8× 3.6k 1.5× 500 0.7× 908 1.6× 830 1.7× 30 4.7k
Jordi Clarimón 1.5k 0.5× 2.2k 0.9× 703 0.9× 891 1.5× 281 0.6× 122 4.9k
Diego Mastroeni 2.8k 1.0× 1.9k 0.8× 642 0.9× 568 1.0× 224 0.5× 60 4.6k
Andréa C. LeBlanc 4.5k 1.5× 2.6k 1.1× 424 0.6× 1.3k 2.2× 635 1.3× 103 6.9k
Ekaterina Rogaeva 3.6k 1.2× 3.4k 1.4× 938 1.2× 1.6k 2.8× 595 1.2× 188 8.3k

Countries citing papers authored by Chang-En Yu

Since Specialization
Citations

This map shows the geographic impact of Chang-En Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang-En Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang-En Yu more than expected).

Fields of papers citing papers by Chang-En Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang-En Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang-En Yu. The network helps show where Chang-En Yu may publish in the future.

Co-authorship network of co-authors of Chang-En Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang-En Yu. A scholar is included among the top collaborators of Chang-En Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang-En Yu. Chang-En Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shofer, Jane B., Eric C. Petrie, Chang-En Yu, et al.. (2017). Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer s Research & Therapy. 9(1). 48–48. 35 indexed citations
2.
Yu, Chang-En & Jessica Foraker. (2015). Epigenetic considerations of the APOE gene. BioMolecular Concepts. 6(1). 77–84. 14 indexed citations
3.
Yang, Yue, C. Dirk Keene, Elaine R. Peskind, et al.. (2015). Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. Journal of Neuropathology & Experimental Neurology. 74(7). 672–687. 31 indexed citations
4.
Cornejo‐Olivas, Mario, Chang-En Yu, Pilar Mazzetti, et al.. (2014). Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease. Neuroscience Letters. 563. 140–143. 6 indexed citations
5.
Yu, Chang-En, Eiron Cudaback, Jessica Foraker, et al.. (2013). Epigenetic signature and enhancer activity of the human APOE gene. Human Molecular Genetics. 22(24). 5036–5047. 53 indexed citations
6.
Bekris, Lynn M., et al.. (2011). Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. Journal of Human Genetics. 57(1). 18–25. 76 indexed citations
7.
Yu, Chang-En, Elizabeth E. Marchani, Georg Nikisch, et al.. (2010). The N141I Mutation in PSEN2. Archives of Neurology. 67(5). 631–3. 9 indexed citations
8.
Li, Ge, Elaine R. Peskind, Steven P. Millard, et al.. (2009). Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects. PLoS ONE. 4(5). e5424–e5424. 117 indexed citations
9.
Sieh, Weiva, Chang-En Yu, Thomas D. Bird, Gerard D. Schellenberg, & Ellen M. Wijsman. (2007). Accounting for Linkage Disequilibrium among Markers in Linkage Analysis: Impact of Haplotype Frequency Estimation and Molecular Haplotypes for a Gene in a Candidate Region for Alzheimer’s Disease. Human Heredity. 63(1). 26–34. 6 indexed citations
10.
Yu, Chang-En, Howard Seltman, Elaine R. Peskind, et al.. (2007). Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association. Genomics. 89(6). 655–665. 123 indexed citations
11.
Sundar, Purnima, Chang-En Yu, Weiva Sieh, et al.. (2006). Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Human Molecular Genetics. 16(3). 295–306. 45 indexed citations
12.
Blander, Gil, Jonathan Kipnis, Juan Fernando Martínez-Leal, et al.. (1999). Physical and Functional Interaction between p53 and the Werner's Syndrome Protein. Journal of Biological Chemistry. 274(41). 29463–29469. 147 indexed citations
13.
Hisama, Fuki M., Junko Oshima, Chang-En Yu, et al.. (1998). Comparison of Methods for Identifying Transcription Units and Transcription Map of the Werner Syndrome Gene Region. Genomics. 52(3). 352–357. 5 indexed citations
14.
Sharma, Vikram, Parvoneh Poorkaj, Fuki M. Hisama, et al.. (1998). An Expression Map from Human Chromosome 14q24.3. Genomics. 47(2). 314–318. 5 indexed citations
15.
Kukull, Walter A., Gerard D. Schellenberg, James D. Bowen, et al.. (1996). Apolipoprotein E in Alzheimer's disease risk and case detection: A case-control study. Journal of Clinical Epidemiology. 49(10). 1143–1148. 42 indexed citations
16.
Yu, Chang-En, et al.. (1996). A YAC, P1, and Cosmid Contig and 17 New Polymorphic Markers for the Werner Syndrome Region at 8p12–p21. Genomics. 35(3). 431–440. 13 indexed citations
17.
Chang, Ming, Joann B. Sweasy, Susanne Edelhoff, et al.. (1994). Evidence against DNA polymerase ? as a candidate gene for Werner syndrome. Human Genetics. 93(5). 507–12. 4 indexed citations
18.
Bonnycastle, Lori L., Chang-En Yu, Clayton R. Hunt, et al.. (1994). Cloning, Sequencing, and Mapping of the Human Chromosome 14 Heat Shock Protein Gene (HSPA2). Genomics. 23(1). 85–93. 77 indexed citations
19.
Gu, Jessie, Xiang Gu, David A. Smith, et al.. (1994). A Panel of Radiation Hybrids for Human Chromosome 8. Genomics. 21(1). 208–216. 8 indexed citations
20.
Oshima, Junko, Chang-En Yu, Michael Boehnke, et al.. (1994). Integrated Mapping Analysis of the Werner Syndrome Region of Chromosome 8. Genomics. 23(1). 100–113. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026